drugset / Trial / NCT02608489
Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is determine whether 3% diquafosol and 0.1% sodium hyaluronate are effective and safe in the treatment of patients with dry eye after cataract surgery.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diquafosol | Oligonucleotide (other) | 3 % | Other |
| Comparator | Sodium Hyaluronate | Other / unclassified | 0.1 % | Other |